OliX Pharmaceuticals, Inc (KOSDAQ:226950)
South Korea · Delayed Price · Currency is KRW 96,300
+4,600 (5.02%)
Oct 10, 2025, 3:30 PM KST
OliX Pharmaceuticals Market Cap
OliX Pharmaceuticals has a market cap or net worth of 1.94 trillion as of October 10, 2025. Its market cap has increased by 635.31% in one year.
Market Cap
1.94T
Enterprise Value
1.96T
Revenue
7.54B
Ranking
n/a
PE Ratio
n/a
Stock Price
96,300.00
Market Cap Chart
Since July 18, 2018, OliX Pharmaceuticals's market cap has increased from 422.03B to 1.94T, an increase of 358.99%. That is a compound annual growth rate of 23.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 1,844.53B | 418.81% |
| Dec 30, 2024 | 355.53B | 52.22% |
| Dec 28, 2023 | 233.57B | -16.24% |
| Dec 29, 2022 | 278.86B | -50.37% |
| Dec 30, 2021 | 561.83B | -17.52% |
| Dec 30, 2020 | 681.17B | 146.02% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.81T |
| Celltrion | 38.64T |
| ALTEOGEN | 25.22T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,144.58B |
| Peptron | 7,006.86B |
| PharmaResearch | 5,714.31B |
| LigaChem Biosciences | 5,545.53B |